Latest News

Trading professionals are increasingly relying on advanced algorithms to interpret live market movements. The speed and complexity of these systems have transformed the way participants navigate shifting conditions and capture opportunities. As data flows become faster and more nuanced, innovations in analytical techniques are shaping the quality of market decisions. Today, real-time market analysis refers [...]

The telecom giant's turnaround is gaining traction, but the market is still pricing the stock for continued challenges.

QuantumScape is about to let investors know if its pilot production "Eagle Line" is delivering battery cells to customers.

The apparel stock hasn't been this cheap in years.

The healthcare giant has been investing heavily in its future growth.

Chinese electric vehicles are quickly becoming a dominant force in the industry, but it hasn’t necessarily translated into profits.

Artificial intelligence (AI) investing doesn't need to break the bank.

In this episode, Fool contributors discuss recent financial results from banking giants Bank of America and Charles Schwab and key providers in the semiconductor industry, Taiwan Semiconductor and ASML.

Apple did in Q1 what others in the smartphone industry couldn't.

The tech sector is only beginning to feel the impact of the helium supply shock.

Expense ratios, yield, and sector exposure set these two global ETFs apart. See how their differences could impact your portfolio strategy.

Finding smaller AI stocks can be more lucrative than chasing yesterday's winners.

A leading U.S. apparel retailer with a strong dividend yield, The Buckle just reported a notable insider sale via trust-held shares.

Brookfield should continue to enrich investors going forward.

This episode covers financial results from Goldman Sachs, plus an update on the U.S. blockade in the Strait of Hormuz and a listener question regarding SpaceX’s upcoming IPO.

Sometimes the most meaningful technological improvements are the simplest ones hiding in plain sight.

This Seattle-based biotech, known for its immune medicine platform, reported a notable insider sale amid ongoing industry partnerships.

Explore how sector focus and portfolio breadth set these two growth ETFs apart for investors weighing diversification against volatility.

Crypto offers big potential, but choosing the right coin isn't easy. Instead, betting on one company that sits at the center of the crypto ecosystem could benefit investors.

Focused on novel immunotherapies for inflammatory diseases, this biotech firm reported significant insider selling in its latest filing.

Chevron gives investors exposure to energy without taking on the risk of a pure-play driller.

The independent power producer will benefit from growing electricity demand from AI data centers in the coming years.